|
2023
|
Invention
|
Methods of treating cancer.
The present invention relates to methods of treating cancer comprisi... |
|
|
Invention
|
Substituted quinazolines for inhibiting kinase activity.
Chemical entities that are kinase inhib... |
|
|
Invention
|
Treatment of asct2-dependent cancers. The present disclosure provides methods of treating or prev... |
|
|
Invention
|
Crystalline salts of crystalline salts of (3s,5r,8r,9s,10s,13r,14s,17r)-14-hydroxy-10,13-dimethyl... |
|
2022
|
Invention
|
Certain chemical entities, compositions, and methods.
Described herein are chemoembolization com... |
|
|
Invention
|
Certain chemical entities, compositions, and methods. Described herein are chemoembolization comp... |
|
|
Invention
|
Substituted quinazolines for inhibiting kinase activity. Chemical entities that are kinase inhibi... |
|
|
Invention
|
Certain chemical entities, compositions, and methods. Chemical entities that are novel compounds,... |
|
2021
|
Invention
|
Certain chemical entities, compositions, and methods.
Chemical entities based on quinoxaline tha... |
|
|
Invention
|
Certain chemical entities, compositions, and methods.
Chemical entities that are novel compounds... |
|
|
Invention
|
Certain chemical entities, compositions, and methods. Chemical entities that are kinase inhibitor... |
|
|
Invention
|
Certain chemical entities, compositions, and methods.
Chemical entities that are kinase inhibito... |
|
2020
|
Invention
|
Certain chemical entities, compositions, and methods.
Chemical entities that are bufalin derivat... |
|
|
Invention
|
Benzenesulfonamide derivatives of quinoxaline, pharmaceutical compositions thereof, and their use... |
|
2019
|
Invention
|
Certain chemical entities, compositions, and methods. Chemical entities based on quinoxaline that... |
|
2018
|
Invention
|
Methods of treating cancer. The present invention relates to methods of treating cancer comprisin... |
|
|
Invention
|
Certain chemical entities, compositions, and methods. Chemical entities that are quinoxaline kina... |
|
2017
|
Invention
|
Substituted quinoxalines for inhibiting kinase activity. Described herein are kinase inhibitors r... |
|
|
Invention
|
Certain steroids and methods for using the same in the treatment of cancer. Chemical entities tha... |
|
2016
|
Invention
|
Substituted quinoxalines as b-raf kinase inhibitors.
Chemical entities that are kinase inhibitor... |
|
2014
|
Invention
|
Certain chemical entities, compositions, and methods.
Chemical entities that are effective as ki... |
